CYP46 Antibodies

Santa Cruz Biotechnology delivers a wide array of CYP46 monoclonal antibodies for various research applications. CYP46 monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CYP46, or cytochrome P450 46A1, plays a crucial role in cholesterol metabolism by catalyzing the conversion of cholesterol to 24-hydroxycholesterol, which is essential for maintaining cholesterol homeostasis in the brain. CYP46 is particularly important in neurobiology, as it is involved in the regulation of cholesterol levels in neuronal cells, impacting neurodegenerative diseases and cognitive function. Understanding CYP46 function is vital for advancing research in neurodegenerative disorders and developing potential therapeutic strategies. Research has shown that CYP46 expression levels can significantly influence brain cholesterol metabolism and neuronal health. Studies indicate that alterations in CYP46 activity may contribute to the development of various neurological conditions. Ongoing investigations continue to reveal new insights about CYP46's role in brain function and disease progression. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of CYP46 and its impact on neurological health.